Subsequently, Zhang et al. reported that FTO facilitates CRC proliferation by targeting the MAF1/c-MYC axis, which can be inhibited by glycogen synthase kinase 3 beta (GSK3β) (Zhang et al., 2021b). The gene discussed is MYC; the disease is colorectal carcinoma.